Good morning check out my [DATE] #chronicillnessVOICE DAILY Newsletter via @Nuzzel  [URL]
#patient #health #medical #research #pharma #advocates
Hello & welcome, I hope you enjoy today's selection.
Please remember some stories may require subscription, some may be commercial ie event promotions, others are not to replace the advice of your own GP's
Wishing you wellness as always
Disabled people will be considered “expendable” under emergency government powers to cope with the coronavirus epidemic, Tanni Grey-Thompson fears. In a bleak speech, the champion Paralympian highlighted how a Bill about to be passed…
FibroFlutters“Decisions will be taken by someone else about our usefulness in the next few months that we will have no control over,” Baroness Grey-Thompson told the House of Lords.
With schools closed and many pharma and healthcare companies asking employees to work from home during the coronavirus outbreak, a lot of us are under pressure to split responsibilities between family and work. pharmaphorum has put together this…
FibroFlutterspharmaphorum has put together this list of easily-accessible online activities that can help educate and entertain children during these busy times.
One of the largest companies developing a drug to treat the novel coronavirus, for which it received an orphan drug designation from the Food and Drug Administration, is now asking the FDA to take that designation back amid a backlash against the…
FibroFluttersA day after receiving orphan drug designation for remdesivir that gave it a fast track to approval and lengthened its market exclusivity, Gilead is requesting the FDA to rescind the designation.
A cancer drug made by Chicago-based AbbVie and Swiss drugmaker Roche was successful in a Phase III confirmatory trial in an aggressive form of leukemia less than a month after failing in another study. AbbVie and Roche said Monday that the Phase…
FibroFluttersAbbVie said the results would be presented at a future medical meeting or published in a peer-reviewed journal.
By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical As the COVID-19 virus continues to wreak havoc across the U.S. and the world, almost no segment of the economy has been spared its impact. That is certainly true of…
FibroFluttersThe FDA is attempting to help sponsors navigate the challenges that now exist. The agency has recently released guidance on the conduct of clinical trials during the COVID-19 pandemic
The Washington Post
– Mar 24, 11:07 AM
He worried if he contracted the virus during his travels, he could die before his weakened immune system could mount a counterattack. But skipping cancer treatments could unleash a disease that had menaced him for six years. “If I let the…
FibroFlutters'A World Health Organization study showed that cancer patients who develop covid-19 have a fivefold risk of dying compared with people without cancer'
Student Nursing Times Awards 2018
– Mar 23, 11:43 AM
Additional beds, staff and intensive care equipment have been made available as private hospitals pitch in to support the NHS through the coronavirus outbreak. A deal has been made between NHS England and the independent sector to allow for an…
FibroFlutters“We all have to play our part to help offset the enormous pressure that our nurses, doctors and other specialists will otherwise face.' - NHS England chief executive Sir Simon Stevens
The COVID-19 pandemic is wreaking havoc on business operations spanning industries, and that's true for biopharma companies rolling out new medicines. Biohaven is in the early stages of launching migraine med Nurtec ODT, and, in response to social…
FibroFluttersIn response, the company is using webinars, telemedicine, DTC and social media to market its drug to both doctors and patients, CEO Vlad Coric said via email.